A New Biphasic Dicalcium Silicate Bone Cement Implant

Current research on bone cements focuses on materials that can support tissue regeneration while maintaining structural integrity. Prior studies have demonstrated that calcium silicate compounds can promote bioactive interactions with bone. However, the biocompatibility and degradation rates of these materials remain uncertain in critical-sized defects. No prior work has resolved how specific processing parameters affect the performance of biphasic dicalcium silicate cements. This gap motivated the development of a new cement formulation with controlled porosity and substitution levels. That uncertainty drove the need to assess how these parameters influence in vitro and in vivo outcomes. It was already known that simulated body fluid testing can predict bioactivity. Yet, the exact mechanism of cell attachment and defect closure remains unclear. This study contributes by evaluating a novel cement in a controlled animal model.

The goal was to evaluate the biocompatibility and in vivo performance of a novel biphasic dicalcium silicate cement. The specific problem addressed is the need for bone cements that can regenerate tissue while maintaining structural support. The motivation stems from the limitations of existing cements, which often fail to integrate with surrounding bone. This study aimed to determine if the new cement could promote bone regeneration in critical-sized defects. The researchers tested the hypothesis that the cement's composition and porosity would influence its performance. The study focused on assessing bioactivity, cell attachment, and bone formation in a controlled model. The primary outcome measure was bone-to-implant contact percentage. The study also aimed to compare the new cement to a non-degradable control.

The cement was synthesized using solid-state processing of α´_L + β-C₂S_ss. The resulting material was used to create a porous cement with low phosphorous substitution. In vitro testing involved soaking cement samples in simulated body fluid and human adipose stem cell cultures. Two 6 mm Ø defects were created in 15 New Zealand rabbit tibias. The cement was implanted into these defects, and bone-to-implant contact was measured histomorphometrically. Residual material volume was tracked over time. Cell attachment was assessed by observing spreading and adhesion after 24 hours. The study compared the cement's performance to a plastic control group. The experimental design included time points at day 60 for maximum bone formation assessment.

The cement formed an apatite-like layer after soaking in simulated body fluid, indicating bioactivity. Cell attachment tests showed that the cement supported cell spreading and adhesion after 24 hours. Histomorphometric analysis revealed a bone-to-implant contact percentage of 55.86 ± 0.23, significantly higher than the control group. Defect closure was observed in the cement-treated group compared to the plastic control. The residual material volume was 35.42 ± 2.08% of the initial value, suggesting controlled degradation. The highest bone formation percentages were recorded on day 60. These findings suggest that the cement promotes initial bone regeneration. The results indicate that the cement's porosity and composition enhance its biocompatibility.

The authors propose that the cement's biphasic composition and porosity contribute to its biocompatibility and bone regeneration potential. These findings suggest that the cement supports cell attachment and defect closure in vivo. The results indicate that the cement's degradation rate is suitable for tissue regeneration. The study implies that the cement's bioactive properties may enhance integration with surrounding bone. The researchers suggest that the cement's performance is superior to non-degradable controls. The study does not claim that the cement is essential for all bone regeneration applications. The findings may support the use of this cement in orthopedic procedures requiring controlled degradation. The authors conclude that the cement's properties make it advantageous for initial bone regeneration.